Safety of drugs used in assisted reproduction techniques (Q36144170)

12 August 2017

1 reference

title

Safety of drugs used in assisted reproduction techniques (English)

1 reference

12 August 2017

Talha Al-Shawaf

1

1 reference

12 August 2017

Ariel Zosmer

series ordinal

2

1 reference

12 August 2017

Martha Dirnfeld

series ordinal

3

1 reference

12 August 2017

Gedis Grudzinskas

series ordinal

4

1 reference

12 August 2017

publication date

1 January 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

28

1 reference

12 August 2017

issue

6

1 reference

12 August 2017

page(s)

513-528

1 reference

Impact of cryopreservation and subsequent embryo transfer on the outcome of in vitro fertilization in patients at high risk for ovarian hyperstimulation syndrome

12 August 2017

cites work

1 reference

12 December 2020

Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study

1 reference

12 December 2020

Preventive attitude of physicians to avoid OHSS in IVF patients

1 reference

12 December 2020

Pregnancies after IVF when high tonic LH is reduced by long-term treatment with GnRH agonists

1 reference

12 December 2020

Follicular stimulation and ovarian cancer

1 reference

12 December 2020

Management of severe ovarian hyperstimulation syndrome by ascitic fluid aspiration and intensive intravenous fluid therapy

1 reference

12 December 2020

Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human Development Women’s Contraceptive and Reproductive Experiences Study

1 reference

12 December 2020

Variation in the biologic and biochemical characteristics of human menopausal gonadotropin

1 reference

12 December 2020

Cryopreservation of all prezygotes in patients at risk of severe hyperstimulation does not eliminate the syndrome, but the chances of pregnancy are excellent with subsequent frozen-thaw transfers

1 reference

12 December 2020

Massive hyperstimulation and borderline carcinoma of the ovary. A possible association

1 reference

12 December 2020

The risk of ovarian cancer after treatment for infertility

1 reference

12 December 2020

Breast and ovarian cancer incidence after infertility and in vitro fertilisation

1 reference

12 December 2020

LHRH agonists in IVF: different methods of utilization and comparison with previous ovulation stimulation treatments

1 reference

12 December 2020

Stimulation of endogenous surge of luteinizing hormone with gonadotropin-releasing hormone analog after ovarian stimulation for in vitro fertilization

1 reference

12 December 2020

The use of high-dose human menopausal gonadotropin in an in vitro fertilization program

1 reference

12 December 2020

The pathogenesis of the ovarian hyperstimulation syndrome

1 reference

12 December 2020

Comparison of gonadotrophin-releasing hormone analogues and human chorionic gonadotrophin for the induction of ovulation and prevention of ovarian hyperstimulation syndrome: a case-control study

1 reference

12 December 2020

Cancer risks associated with the diagnosis of infertility

1 reference

12 December 2020

Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Collaborative Ovarian Cancer Group

1 reference

12 December 2020

Risk of cancer after use of fertility drugs with in-vitro fertilisation

1 reference

12 December 2020

Fertility drugs and ovarian cancer: red alert or red herring?

1 reference

12 December 2020

Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist Cetrorelix in healthy female volunteers

1 reference

12 December 2020

The incidence of multiple gestations after in vitro fertilization is dependent on the number of embryos transferred and maternal age.

1 reference

12 December 2020

Laparoscopic unwinding of adnexal torsion caused by ovarian hyperstimulation

1 reference

12 December 2020

The Economic Impact of Multiple-Gestation Pregnancies and the Contribution of Assisted-Reproduction Techniques to Their Incidence

1 reference

12 December 2020

Coexistent hemoconcentration and hypoosmolality during superovulation and in severe ovarian hyperstimulation syndrome: a volume homeostasis paradox

1 reference

12 December 2020

Early miscarriage and fetal malformations after induction of ovulation (by clomiphene citrate and/or human menotropins), in vitro fertilization, and gamete intrafallopian transfer

1 reference

12 December 2020

Intravenous albumin does not prevent the development of severe ovarian hyperstimulation syndrome in an in-vitro fertilization programme

1 reference

12 December 2020

High pregnancy rates and successful prevention of severe ovarian hyperstimulation syndrome by 'prolonged coasting' of very hyperstimulated patients: a multicentre study

1 reference

12 December 2020

Hydroxyethylstarch versus human albumin for the treatment of severe ovarian hyperstimulation syndrome: a preliminary report

1 reference

12 December 2020

GnRH antagonist in assisted reproduction: a Cochrane review

1 reference

12 December 2020

Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome

1 reference

12 December 2020

Ovulation and ovarian cancer

1 reference

12 December 2020

One thousand initiated cycles of in vitro fertilization in women > or = 40 years of age.

1 reference

12 December 2020

Diagnosis, prevention and management of ovarian hyperstimulation syndrome.

1 reference

12 December 2020

An ounce of prevention: outpatient management of the ovarian hyperstimulation syndrome

1 reference

12 December 2020

Are children born after assisted reproductive technology at increased risk for adverse health outcomes?

1 reference

12 December 2020

Risk of endometrial cancer after use of fertility drugs

1 reference

12 December 2020

Characteristics relating to ovarian cancer risk: collaborative analysis of 12 U.S. case-control studies. VI. Nonepithelial cancers among adults. Collaborative Ovarian Cancer Group

1 reference

12 December 2020

Fertility drugs may not increase risk of invasive ovarian cancer

1 reference

12 December 2020

In vitro fertilization/embryo transfer in the United States: 1985 and 1986 results from the National IVF/ET Registry. Medical Research International. The American Fertility Society Special Interest Group

1 reference

12 December 2020

Cancer incidence in a cohort of infertile women

1 reference

12 December 2020

Development and applications of luteinizing hormone-releasing hormone antagonists in the treatment of infertility: an overview

1 reference

12 December 2020

Intravenous albumin for the prevention of severe ovarian hyperstimulation syndrome in an in vitro fertilization program: a prospective, randomized, placebo-controlled study.

1 reference

12 December 2020

Uterine and ovarian carcinoma in a patient receiving gonadotrophin therapy. Case report

1 reference

12 December 2020

Molecular mechanisms of ligand interaction with the gonadotropin-releasing hormone receptor

1 reference

12 December 2020

The genital anomaly associated with prenatal exposure to progestogens

1 reference

12 December 2020

Angiotensin II immunoreactivity is elevated in ascites during severe ovarian hyperstimulation syndrome: implications for pathophysiology and clinical management

1 reference

12 December 2020

Outcome of pregnancies inadvertently exposed to gonadotropin-releasing hormone analogues (GnRH-a) in early gestation

1 reference

12 December 2020

Ovarian hyperstimulation syndrome: an endocrinopathy?

1 reference

12 December 2020

Intra-venous albumin for preventing severe ovarian hyperstimulation syndrome

1 reference

12 December 2020

Obstetric outcome and follow-up of children born after in vitro fertilization (IVF).

1 reference

12 December 2020

Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment

1 reference

12 December 2020

The use of GnRH antagonists in ovarian stimulation.

1 reference

12 December 2020

Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group

1 reference

12 December 2020

Severe ovarian hyperstimulation syndrome using agonists of gonadotropin-releasing hormone for in vitro fertilization: a European series and a proposal for prevention

1 reference

12 December 2020

Adverse local reaction to intramuscular injections of urinary-derived gonadotrophins

1 reference

12 December 2020

The questionable use of albumin for the prevention of ovarian hyperstimulation syndrome in an IVF programme: a randomized placebo-controlled trial

1 reference

12 December 2020

Clinical applications of LHRH analogues

1 reference

12 December 2020

Relationship of timing of agonist administration in the cycle phase to the ovarian response to gonadotropins in the long down-regulation protocols for assisted reproductive technologies.

1 reference

12 December 2020

Value of measuring serum FSH in addition to serum estradiol in a coasting programme to prevent severe OHSS.

1 reference

12 December 2020

Assisted reproductive technology in Europe, 2000. Results generated from European registers by ESHRE.

1 reference

12 December 2020

Assisted reproductive technology and the incidence of ovarian cancer: a meta-analysis

1 reference

12 December 2020

Outcome of inadvertent administration of a gonadotrophin-releasing hormone agonist (buserelin) in early pregnancy

1 reference

12 December 2020

Neonatal data on a cohort of 2889 infants born after ICSI (1991-1999) and of 2995 infants born after IVF (1983-1999).

1 reference

12 December 2020

Severe ovarian hyperstimulation syndrome: is it really preventable by prophylactic intravenous albumin?

1 reference

12 December 2020

Embryo freezing for preventing ovarian hyperstimulation syndrome: a Cochrane review

1 reference

12 December 2020

Luteal phase support in assisted reproduction cycles

1 reference

12 December 2020

Ovarian carcinoma in a patient hyperstimulated by gonadotropin therapy for in vitro fertilization: a case report

1 reference

12 December 2020

Hypospadias, androgen biosynthesis, and synthetic progestogens during pregnancy

1 reference

12 December 2020

Borderline malignancy of the ovary and controlled hyperstimulation, a report of 2 cases

1 reference

12 December 2020

Introduction of blastocyst culture and transfer for all patients in an in vitro fertilization program

1 reference

12 December 2020

Prevention and treatment of ovarian hyperstimulation syndrome

1 reference

12 December 2020

Preimplantation genetic diagnosis for advanced maternal age and other indications.

1 reference

12 December 2020

A retrospective case-control study of developmental and other outcomes in a cohort of Australian children conceived by intracytoplasmic sperm injection compared with a similar group in the United Kingdom.

1 reference

12 December 2020

Clinical evaluation of three different gonadotrophin-releasing hormone analogues in an IVF programme: a prospective study

1 reference

12 December 2020

Persistent ascites after ovarian hyperstimulation syndrome and administration of mifepristone (RU 486) for the termination of pregnancy

1 reference

12 December 2020

Breast cancer in women with recent exposure to fertility medications is associated with poor prognostic features

1 reference

12 December 2020

Classification and pharmacology of progestins

1 reference

12 December 2020

Cancer risk after evaluation for infertility

1 reference

12 December 2020

Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study

1 reference

12 December 2020

Delay of gonadotropin stimulation in patients receiving gonadotropin-releasing hormone agonist (GnRH-a) therapy permits increased clinic efficiency and may enhance in vitro fertilization (IVF) pregnancy rates

1 reference

12 December 2020

Preimplantation diagnosis for aneuploidies in patients undergoing in vitro fertilization with a poor prognosis: identification of the categories for which it should be proposed.

1 reference

12 December 2020

Ovarian hyperstimulation syndrome

1 reference

12 December 2020

Incidence of congenital malformations in children born after ICSI

1 reference

12 December 2020

Nationwide data on falling incidence of ovarian granulosa cell tumours concomitant with increasing use of ovulation inducers

1 reference

12 December 2020

Fetal genital effects of first-trimester sex hormone exposure: a meta-analysis

1 reference

12 December 2020

Gonadotropin-releasing hormone and its analogues: from laboratory to bedside

1 reference

12 December 2020

Luteal phase support in infertility treatment: a meta-analysis of the randomized trials

1 reference

12 December 2020

An increased risk of breast cancer after delayed first parity

1 reference

12 December 2020

Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization

1 reference

12 December 2020

Is there a risk of prion disease after the administration of urinary-derived gonadotrophins?

1 reference

12 December 2020

Progestogen therapy during pituitary desensitization with gonadotropin-releasing hormone agonist prevents functional ovarian cyst formation: a prospective, randomized study

1 reference

12 December 2020

Ovarian cancer and fertility medications: a critical appraisal

1 reference

12 December 2020

Ovarian tumors in a cohort of infertile women

1 reference

12 December 2020

Should we still advise infertile couples to use (barrier) contraception before IVF down-regulation?

1 reference

12 December 2020

Childhood tumor risk after treatment with ovulation-stimulating drugs

1 reference

12 December 2020

1 reference

12 December 2020

'Prolonged coasting': an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization

1 reference

12 December 2020

'Early coasting' in patients with polycystic ovarian syndrome is consistent with good clinical outcome

1 reference

12 December 2020

Severe ovarian hyperstimulation syndrome: a reevaluated therapeutic approach

1 reference

12 December 2020

Cancer incidence in a cohort of infertile women who underwent in vitro fertilization

1 reference

12 December 2020

The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization

1 reference

12 December 2020

Persistent elevation of serum oestradiol levels by functional ovarian cysts despite effective pituitary desensitization with GnRH agonists

1 reference

12 December 2020

Ovarian hyperstimulation syndrome: an update review.

1 reference

12 December 2020

A novel approach for patients at risk for ovarian hyperstimulation syndrome: elective transfer of a single zona-free blastocyst on day 5.

1 reference

12 December 2020

A prospective randomized study to assess the clinical efficacy of gonadotrophins administered subcutaneously and intramuscularly

1 reference

12 December 2020

Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified 'coasting' strategy based on ultrasound for identification of high-risk patients

1 reference

12 December 2020

Early and late presentation of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors

1 reference

12 December 2020

Safety of GnRH agonists and antagonists

1 reference

12 December 2020

The difference in miscarriage rates between menotropin-induced and natural cycle pregnancies is not surveillance related

1 reference

12 December 2020

Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol

1 reference

12 December 2020

Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome.

1 reference

12 December 2020

Factors associated with pregnancy or miscarriage after clomiphene therapy in WHO group II anovulatory women

1 reference

12 December 2020

The management of predicted ovarian hyperstimulation involving gonadotropin-releasing hormone analog with elective cryopreservation of all pre-embryos

1 reference

12 December 2020

Safety issues in assisted reproduction technology. From theory to reality--just what are the data telling us about ICSI offspring health and future fertility and should we be concerned?

1 reference

12 December 2020

Preimplantation diagnosis of repeated miscarriage due to chromosomal translocations using metaphase chromosomes of a blastomere biopsied from 4- to 6-cell-stage embryos

1 reference

12 December 2020

Birth after the reimplantation of a human embryo

1 reference

12 December 2020

Distinction between early and late ovarian hyperstimulation syndrome

1 reference

12 December 2020

Ovarian stimulation and granulosa-cell tumour

1 reference

12 December 2020

Ovarian hyperstimulation syndrome after superovulation using GnRH agonists for IVF and related procedures

1 reference

12 December 2020

Follicular stimulation for high tech pregnancies: are we playing it safe?

1 reference

12 December 2020

Withholding gonadotropins ("coasting") to minimize the risk of ovarian hyperstimulation during superovulation and in vitro fertilization-embryo transfer cycles

1 reference

12 December 2020

does intravenous administration of human albumin prevent severe ovarian hyperstimulation syndrome?

1 reference

12 December 2020

Ovarian carcinoma masquerading as ovarian hyperstimulation syndrome

1 reference

12 December 2020

Severe ovarian hyperstimulation despite prophylactic albumin at the time of oocyte retrieval for in vitro fertilization and embryo transfer

1 reference

12 December 2020

Implantation, abortion, and birth after in vitro fertilization using the natural menstrual cycle or follicular stimulation with clomiphene citrate and human menopausal gonadotropin

1 reference

12 December 2020

Follicle cyst formation after administration of different gonadotrophin-releasing hormone analogues for assisted reproduction

1 reference

12 December 2020

The use of intravenous albumin in patients at high risk for severe ovarian hyperstimulation syndrome

1 reference

12 December 2020

Comparison between different routes of progesterone administration as luteal phase support in infertility treatments

1 reference

12 December 2020

Direct ovarian effects and safety aspects of GnRH agonists and antagonists

1 reference

12 December 2020

Ovarian hyperstimulation syndrome: prediction by number and size of preovulatory ovarian follicles

1 reference

12 December 2020

Reducing the Risk of Multiple Births by Transfer of Two Embryos after in Vitro Fertilization

1 reference

12 December 2020

Luteal phase support and severe ovarian hyperstimulation syndrome

1 reference

12 December 2020

Comparative pharmacokinetics of two urinary human follicle stimulating hormone preparations in healthy female and male volunteers

1 reference

12 December 2020

Reproductive technology--the price of progress

1 reference

12 December 2020

Two cases of ovarian tumours in women who had undergone multiple ovarian stimulation attempts

1 reference

12 December 2020

Risk of breast cancer in a cohort of infertile women

1 reference

12 December 2020

Recombinant human follicle-stimulating hormone versus urinary-derived human menopausal gonadotropin for controlled ovarian stimulation: the science and art of assisted reproductive technologies

1 reference

12 December 2020

Treatment of hyperstimulation during in-vitro fertilization

1 reference

12 December 2020

Preimplantation aneuploidy screening using comparative genomic hybridization or fluorescence in situ hybridization of embryos from patients with recurrent implantation failure

1 reference

12 December 2020

Pituitary apoplexy after leuprolide injection for ovum donation

1 reference

12 December 2020

Ovarian cancer risk after the use of ovulation-stimulating drugs

1 reference

12 December 2020

Subcutaneously administered Repronex in oligoovulatory female patients undergoing ovulation induction is as effective and well tolerated as intramuscular human menopausal gonadotropin treatment

1 reference

12 December 2020

10.2165/00002018-200528060-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

12 August 2017

1024498190

0 references

1 reference